Thanks to the support of DKMS Access To Treatment, children like seven-year-old Avukile from South Africa gain access to life-saving treatment and thus a second chance at life. © DKMS
Press Release

DKMS launches new organization for better access to treatment

The Global Executive Team, Prof. Dr. Johannes Schetelig, Global Chief Scientific and Medical Officer, together with Katharina Harf, Chair of the Foundation Board and Global Chief Strategy Officer, Dr. Elke Neujahr, Global CEO of DKMS, as well as Bernd Weinel, Chief Financial Officer.
Press Release

Katharina Harf and Prof. Dr. Johannes Schetelig Join DKMS’s Global Executive Management Team

Professor Dr. Johannes Schetelig the first Global Chief Scientific Officer at DKMS
Press Release

DKMS Strengthens Scientific Leadership: Prof. Dr. Johannes Schetelig Appointed Global Chief Scientific Officer

1 /

Press Center

Welcome to the Press Center, your comprehensive source for the latest news, updates, and resources about our global mission to fight blood cancer and other life-threatening blood disorders. Stay connected to learn how DKMS empowers people worldwide to become potential lifesaving donors and make a lasting impact.